0001193125-26-312694 Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 23rd, 2026 • MindWalk Holdings Corp. • Pharmaceutical preparations

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of July 16, 2024, is between IMMUNOPRECISE ANTIBODIES LTD., a British Columbia corporation, with principal executive offices located at 3204-4464 Markham Street, Victoria, BC V8Z 7X8 (the “Company”), and each of the investors listed on the Schedule of Buyers attached as Schedule I hereto (individually, a “Buyer” and collectively the “Buyers”).

View Source
GLOBAL GUARANTY AGREEMENT
Global Guaranty Agreement • July 23rd, 2026 • MindWalk Holdings Corp. • Pharmaceutical preparations • New York

This Guaranty is made as of July 16, 2024 by ImmunoPrecise Antibodies (Canada), Ltd., British Columbia corporation (“ImmunoCanada”), ImmunoPrecise Antibodies (Europe) BV, a company incorporated in the Netherlands (“ImmunoDutch”), and BioStrand B.V., a company incorporated in Belgium ((“BioStrand”) and collectively with ImmunoCanada and ImmunoDutch, the “Guarantors”) in favor of YA II PN, LTD. (“YA II” or the “Creditor”), with respect to all obligations of ImmunoPrecise Antibodies Ltd. a British Columbia corporation (the “Debtor”) owed to the Creditor.

View Source
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 23rd, 2026 • MindWalk Holdings Corp. • Pharmaceutical preparations

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 16, 2024 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and IMMUNOPRECISE ANTIBODIES LTD., a British Columbia corporation (the “Company”). The Investor and the Company may be referred to herein individually as a “Party” and collectively as the “Parties.”

View Source
SECURITIES PURCHASE AGREEMENT by and among BUYER, IMMUNOPRECISE NETHERLANDS B.V.,
Securities Purchase Agreement • July 23rd, 2026 • MindWalk Holdings Corp. • Pharmaceutical preparations • Delaware

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of August 6, 2025 (the “Effective Date”), by and among AVS Bio Netherlands B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (“Buyer”), ImmunoPrecise Netherlands B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (“Seller”), ImmunoPrecise Antibodies (Europe) B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (the “Company”) and, solely for the purposes of Section 7.03 and Article VIII hereof, ImmunoPrecise Antibodies Ltd., a corporation incorporated under the laws of the province of British Columbia (“Parent”, and together with Buyer and Seller collectively, the “Parties”, and each, individually, a “Party”).

View Source